KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Gross Margin (2016 - 2025)

Historic Gross Margin for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to 42.24%.

  • Fulgent Genetics' Gross Margin rose 49300.0% to 42.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 41.24%, marking a year-over-year increase of 50300.0%. This contributed to the annual value of 37.82% for FY2024, which is 17100.0% up from last year.
  • As of Q3 2025, Fulgent Genetics' Gross Margin stood at 42.24%, which was up 49300.0% from 42.1% recorded in Q2 2025.
  • Fulgent Genetics' 5-year Gross Margin high stood at 80.92% for Q3 2021, and its period low was 19.18% during Q4 2022.
  • For the 5-year period, Fulgent Genetics' Gross Margin averaged around 48.32%, with its median value being 42.1% (2025).
  • As far as peak fluctuations go, Fulgent Genetics' Gross Margin surged by 317200bps in 2021, and later crashed by -561300bps in 2022.
  • Over the past 5 years, Fulgent Genetics' Gross Margin (Quarter) stood at 75.31% in 2021, then tumbled by -75bps to 19.18% in 2022, then soared by 87bps to 35.78% in 2023, then rose by 17bps to 41.79% in 2024, then rose by 1bps to 42.24% in 2025.
  • Its last three reported values are 42.24% in Q3 2025, 42.1% for Q2 2025, and 38.59% during Q1 2025.